Recap of "Closing Bell" - 5/28/09
Next Recap: 
For Full Access to 5000+ Stock Reports,
Real Time Stock News Tracking and
All of Ockham's Financial Information Services
Ockham's daily Recap of Closing Bell.
Listed below are stocks that were mentioned in CNBC's Closing Bell on Thursday May, 28th.
The last hour of the trading day can be extremely important as volatile swings can work with or against the investor. CNBC’s Closing Bell hosted by the duo of Maria Bartiromo and Dylan Ratigan will guide investors into the end of the day’s trading live from the NYSE. Interviews with industry movers and shakers lend unique viewpoints to the day’s events. Stocks mentioned during the two hour program (beginning at 3pm ET) are listed below with accompanying research.
Want to know everything that was said on Closing Bell? Then you have to watch it. Visit CNBC for show times and channel guides.
CNBC - Closing Bell Stock Commentary for 5/28/2009
|
4:37P, May. 28,2009
CBSH
$30.84 Commerce Bancshares, Inc.
 Commerce Bancshares, Inc. (CBSH) Discussed on CNBC's Closing Bell Commerce Bancshares, Inc. is in the news. Find out how this impacts CBSH trading on Ockham Research. So I don't believe they favor consolidation within canada. That means for us if we're going to grow really only major acquisitions we can do is in the >> and, of course, the COMMERCE BANK deal was a good deal and certainly way before the financial meltdown in the united states. How's that integration going? What needs to be done? “… n in the united states. How's that integration going? What needs to be done? …” |
|
3:55P, May. 28,2009
EXEL
$5.30 Exelixis, Inc.
Exelixis, Incorporated (EXEL) Discussed on CNBC's Closing Bell Exelixis, Incorporated is in the news. Find out how this impacts EXEL trading on Ockham Research. Apparently they're going to pull >> unbelievable. We'll keep watching the gm story for you. >>> other stocks under the radar EXELIXIS shares under the move. Cancer treatment products from the biotech company. They will pay $140 million for the two drugs which are in phase clinical trials. Guaranteeing $21 million in research funding over the next “… hich are in phase clinical trials. Guaranteeing $21 million in research funding over the next …” |
|
3:38P, May. 28,2009
NFX
$36.31 Newfield Exploration Company
Newfield Exploration Company (NFX) Discussed on CNBC's Closing Bell Newfield Exploration Company is in the news. Find out how this impacts NFX trading on Ockham Research. Acquired if we see crude oil pushing back toward $70, $ 5 toward year end. We're hearing a lot of chatter about that now. The little ones, nimble names on the list, NEWFIELD EXPLORATION, plains energy, simmer rex, those are the ones I would be a more aggressive buyer of. >> catch you soon. >>> coming up on "fast money," oil stocks helping the markets “… essive buyer of. >> catch you soon. >>> coming up on "fast money," oil stocks helping the markets …” |